Results 11 to 20 of about 23,913 (202)
G6PD diaxBox: Digital image-based quantification of G6PD deficiency
Talanta, 2021 Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzymopathy in humans. More than 400 million people worldwide are affected by this genetic condition. Testing for G6PD deficiency before drug administration is essential for patient safety. Rapidly ascertaining the G6PD status of a person is desirable for proper treatment.
Duangdao Palasuwan +5 more
openaire +2 more sources
Molecular analysis of three novel G6PD variants: G6PD Pedoplis-Ckaro, G6PD Piotrkow and G6PD Krakow.
Acta Biochimica Polonica, 2007 We present three novel mutations in the G6PD gene and discuss the changes they cause in the 3-dimensional structure of the enzyme: 573C-->G substitution that predicts Phe to Leu at position 191 in the C-terminus of helix alphae, 851T-->C mutation which results in the substitution 284Val--> -->Ala in the beta+alpha domain close to the C ...
Maciag, Monika +8 more
openaire +4 more sources
Septic arthritis of the shoulder joint in a child with sickle cell trait and G6PD deficiency
Journal of Integrative Medicine and Research, 2023 Septic arthritis, osteomyelitis, and osteonecrosis are known complications of sickle cell disease in children. However, similar complications in cases of sickle cell trait (SCT) are infrequent.
Jenith Vijayalakshmi +4 more
doaj +1 more source
Tafenoquine and G6PD: A Primer for Clinicians [PDF]
Journal of Travel Medicine, 2019 Tafenoquine, an 8-aminoquinoline, is now indicated for causal prophylaxis against all human malarias and as radical curative (anti-relapse) treatment against Plasmodium vivax and Plasmodium ovale. As with other 8-aminoquinolines, tafenoquine causes hemolysis in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency (hemizygous males and ...
Chu, CS, Freedman, DO
openaire +2 more sources
Mediterranean Journal of Hematology and Infectious Diseases, 2021 Introduction: Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common X-linked enzymopathy, highly prevalent in areas where malaria is or has been endemic. Prevalence of G6PD deficiency and characterization of G6PD variants in females from
Sumalai Dechyotin +6 more
doaj +3 more sources
The enzymopathy of G6PD deficiency in Jordan: a demographic and biochemical analysis
Asian Journal of Medical Sciences, 2018 Background: G6PD deficiency is an inherited X-linked recessive condition leading to insufficient levels of glucose-6-phosphate dehydrogenase, thus causing hemolytic anaemia under certain circumstances.
Ahmed Al-Imam
doaj +1 more source
Biomolecules, 2019 Giardia lambia is a flagellated protozoan parasite that lives in the small intestine and is the causal agent of giardiasis. It has been reported that G. lamblia exhibits glucose-6-phosphate dehydrogenase (G6PD), the first enzyme in the pentose phosphate ...
Laura Morales-Luna +17 more
doaj +1 more source
Dr. Sulaiman Al Habib Medical Journal, 2020 Glucose-6-phosphate Dehydrogenase (G6PD) deficiency is an X-linked disorder that mainly affects red blood cells resulting in its lysis manifesting as hemolytic anemia.
Zair Hassan +3 more
doaj +1 more source
Angewandte Chemie, EarlyView.An efficient radiosynthesis of fluorine‐18 labeled gluconic acid ([18F]FGA) was developed using two readily available materials, 2‐deoxy‐2‐[18F]fluoro‐D‐glucose ([18F]FDG) and glucose oxidase. [18F]FGA is highly specific for bacterial gluconate metabolism mediated by gluconate permease (GntP) and gluconate kinase (GntK), with rapid clearance, low off ...
Sang Hee Lee +7 more
wiley +2 more sources
Erciyes Medical Journal, 2020 Glucose-6-phosphate dehydrogenase is an enzyme that protects the erythrocytes against oxidative damage. G6PD deficiency is a common disorder in Gulf Countries that may present with hemolytic anemia and acute renal failure after exposure to oxidative ...
Esra Ermis Turak +9 more
doaj +1 more source